Discontinued ProductUnfortunately Burimamide oxalate (Cat. No. 1857) has been withdrawn from sale for commercial reasons.
Histamine H3/H2 receptor antagonist (Ki values are 0.07, 7.8 and 290 μM for H3, H2 and H1 receptors respectively). Displays partial agonist activity in SK-N-MC cells. Produces antinociceptive effects following intraventricular administration (ED50 = 183 nmol/mouse in hot-plate test).
|Storage||Desiccate at +4°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
References are publications that support the products' biological activity.
Lamberti et al (1996) Investigation into the role of histamine receptors in rodent antinociception. Pharmacol.Biochem.Behav. 53 567 PMID: 8866956
Hough et al (2000) Antinociceptive activity of derivatives of improgran and burimamide. Pharmacol.Biochem.Behav. 65 61 PMID: 10638637
View Related Products by Product Action
Keywords: Burimamide oxalate, supplier, Mixed, H2/H3, antagonists, H3, Receptors, Histamine, H2, histaminergic, Histamine, H2, Receptors, Histamine, H3, Receptors, Histamine, H2, Receptors, Tocris Bioscience
Citations for Burimamide oxalate
Citations are publications that use Tocris products.
Currently there are no citations for Burimamide oxalate.
Reviews for Burimamide oxalate
There are currently no reviews for this product. Be the first to review Burimamide oxalate and earn rewards!
Have you used Burimamide oxalate?
Submit a review and receive an Amazon gift card.
$10US/$10CAN/€7/£6 gift card for a review without an image
$25US/$25CAN/€18/£15 gift card for a review with an image
*Offer only valid in the USA / Canada, UK and EuropeSubmit a Review
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.